None
Quote | Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX)
Last: | $1.635 |
---|---|
Change Percent: | 0.31% |
Open: | $1.63 |
Close: | $1.63 |
High: | $1.69 |
Low: | $1.6 |
Volume: | 2,365,198 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX)
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a...
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., ...
Message Board Posts | Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $LXRX News Article - Lexicon To Present Results From LX9211 Phase 2 Trial In Postherpet | whytestocks | investorshangout | 04/21/2023 4:35:49 PM |
Passing 2.69. | BooDog | investorshub | 04/17/2023 1:50:06 PM |
Let's get the move on. | BooDog | investorshub | 04/14/2023 2:51:12 PM |
PUDUFA coming in a couple months. Looks | BooDog | investorshub | 03/06/2023 2:36:59 PM |
znewcar1: $LXRX 22% v1,7M c2.68 f188,725M H2.85 ML2.13=RL | znewcar1 | investorshangout | 03/03/2023 10:04:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Lexicon Pharmaceuticals Inc. Company Name:
LXRX Stock Symbol:
NASDAQ Market:
Lexicon Pharmaceuticals Inc. Website:
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that senior company execut...
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a...
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice president and chief commercial officer, and Craig Granowitz, M.D., ...